Quick Answer
Actinium Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 31.20 million shares for the year ending 2025.
- Actinium Pharmaceuticals, Inc. showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Actinium Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Actinium Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 179.7%.
- Historical annual values: Fiscal year 2025: 31.20 million shares | Fiscal year 2024: 31.20 million shares | Fiscal year 2023: 27.63 million shares | Fiscal year 2022: 25.67 million shares | Fiscal year 2021: 22.14 million shares | Fiscal year 2020: 17.53 million shares | Fiscal year 2019: 5.49 million shares | Fiscal year 2018: 115.70 million shares | Fiscal year 2017: 80.07 million shares | Fiscal year 2016: 55.80 million shares | Fiscal year 2015: 44.07 million shares | Fiscal year 2014: 29.97 million shares | Fiscal year 2013: 24.57 million shares | Fiscal year 2012: 21.39 million shares | Fiscal year 2011: 13.66 million shares | Fiscal year 2010: 11.16 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: